Principal investigator: Prof. Dr. Klaus Benndorf
DFG (SFB/TR 166) 2015-2020
Projektleiterin: Prof. Dr. Britta Qualmann
DFG 2020-2020
Metabotropic glutamate receptors (mGluRs) are G-protein coupled receptors, forming obligatory dimers. We investigated the glutamate-induced kinetics of the receptors using FRET in membrane patches exposed to fast concentration jumps. We were able to resolve the kinetics of mGluR1, proving a speed comparable to Rhodopsin. The study was extended to all 8 known mGluR isoforms, while also investigating their potential heteromeric forms and their kinetics.
Principal investigator: apl. Prof. Dr. Thomas Zimmer
The aim of our project is to better understand excitation processes in the normal and diseased heart by electrophysiological and molecular biology techniques. This includes optogenetic investigations on the effect of individual ion channels on action potentials, the identification of genotype-phenotype correlations in cardiac channelopathies, investigations on the therapeutic effect of antiarrhythmic drugs, and the development of novel optogenetic tools.
Principal investigator: Dr. Vasilica Nache
DFG 2020 - 2023
Retinitis pigmentosa is the most common form of inherited retinal degeneration and is characterized by progressive vision loss that eventually leads to complete blindness. Currently, there is no drug therapy available. The aim of this project is to develop and functionally characterize selective modulators of retinal cyclic nucleotide-gated channels (CNG). In addition, the therapeutic potential of these compounds in retinal-degenerative diseases characterized by a disruption of cellular cGMP homeostasis will be investigated.